• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MICROVENTION, INC. HP8 AZUR HYDROPACK 18; DEVICE, VASCULAR, FOR PROMOTING EMBOLIZATION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MICROVENTION, INC. HP8 AZUR HYDROPACK 18; DEVICE, VASCULAR, FOR PROMOTING EMBOLIZATION Back to Search Results
Model Number 45-880020
Medical Device Problem Codes Migration (4003); Premature Separation (4045)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 04/08/2026
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
A search for non-conformances associated with this part/lot number combination did not reveal any production-related issues relevant to the complaint that occurred during manufacturing of the device.The device has been returned to the manufacturer for evaluation.The investigation is ongoing.Upon completion of the investigation, a supplemental mdr will be submitted.
 
Event or Problem Description
As reported: embo bleed case of vessel off celiac artery, 5fr right femoral artery access followed by catheter, and then followed by 0.021 microcatheter to target area.Various coils deployed before reported coil was inserted.Coil was inserted into microcatheter without incident.Coil placement was not satisfactory for physician and retrieval of the coil was attempted.It was discovered that the coil had detached from the delivery system.The coil traveled to a non-target area.A small snare was inserted to remove the hydropack coil that traveled to an unintended target, successful removal of hydropack via snare.Patient stable post procedure.
 
Additional Manufacturer Narrative
The investigation of the returned coil system found the implant coil separated from the pusher, stretched and broken at the proximal section, and was returned entangled on a snare, which is consistent with the condition of the implant described in the reported event.However, the attachment monofilament was not present in the implant; furthermore, the portion of the implant proximal to the break site and the pusher were not returned for evaluation.Without the return and evaluation of the pusher and monofilament, the investigation is unable to determine the mode of separation (i.E., unintentional vs normal detachment using a detachment controller).The investigation could not verify the mode of implant separation due to the absence of the pusher and monofilament.Furthermore, no procedure imaging/videos were provided for review; therefore, the investigation could not determine if the implant migrated to a non-target area as described in the reported event.The physical evaluation of the device could not identify the conditions or circumstances that led to the stretched and broken implant, but the damage is consistent with the device experiencing forces exceeding the implant's yield and tensile strength during removal with the snare.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HP8 AZUR HYDROPACK 18
Common Device Name
DEVICE, VASCULAR, FOR PROMOTING EMBOLIZATION
Manufacturer (Section D)
MICROVENTION, INC.
35 enterprise
aliso viejo CA 92656
Manufacturer Contact
terrence callahan
35 enterprise
aliso viejo, CA 92656
7142478000
MDR Report Key25050905
Report Number2032493-2026-00292
Device Sequence Number10410855
Product Code KRD
UDI-Device Identifier00842429118054
UDI-Public00842429118054
Combination Product (Y/N)N
Initial Reporter StateTX
Initial Reporter CountryUS
PMA/510(K) Number
K223050
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional,User Facility,Company Representative
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 06/16/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model Number45-880020
Device Lot Number0001115775
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer04/24/2026
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 04/08/2026
Supplement Date Received by Manufacturer06/15/2026
Initial Report FDA Received Date04/30/2026
Supplement Report FDA Received Date06/16/2026
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured06/03/2025
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
MIK CATHETER.; TRUSELECT 0.021 MICROCATHETER.
Outcome Attributed to Adverse Event Required Intervention;
Patient SexUnknown
-
-